Ads
related to: weekly chemo for ovarian cancer- Treatment Effectiveness
Read About How Treatment Works And
Its Benefits And Risks In Patients.
- About PARP Inhibitors
Learn About How Treatment Works.
Learn About Maintenance Therapy.
- Talk To Your Doctor
Get Resources To Help Stay Informed
To Make Your Conversation Easier.
- Tablet Dosing Info
Learn About Tablet Dosing For
An Ovarian Cancer Treatment.
- First-Line Maintenance
Learn About First-Line Treatment.
Download Helpful Resources & Info.
- Safety And Side Effects
Read Important Safety Information.
Learn More About A Treatment.
- Treatment Effectiveness
Search results
Results From The WOW.Com Content Network
For example, in standard treatment of ovarian cancer, paclitaxel is given at 175 mg/m 2 body surface every three weeks. In dose dense therapy paclitaxel is given at 50–80 mg/m 2 every week (150–240 mg/m 2 in 3-weeks).
Docetaxel is used in the treatment of various cancers, including breast, lung, prostate, gastric, head and neck, and ovarian cancer. [6] Clinical data have shown docetaxel to have cytotoxic activity against breast, colorectal, lung, ovarian, prostate, liver, renal, gastric, and head and neck cancers and melanoma. [ 12 ]
Despite the encouraging results, there are not many clinical trials using metronomic therapy for ovarian cancer. Most of the findings are from case reports and pre-clinical trials. Due to few clinical trials and lack of information about the applications, it is still risky and questionable to substitute conventional therapy used in treatment of ...
Platinum-based chemotherapy is paramount to treatment of epithelial ovarian cancer. Carboplatin tends to fare better than cisplatin for side effects and use in outpatient setting in randomized clinical trials. [4] Paclitaxel is a particularly effective add-on for late stage ovarian cancer. [4]
Paclitaxel, sold under the brand name Taxol among others, is a chemotherapy medication used to treat ovarian cancer, esophageal cancer, breast cancer, lung cancer, Kaposi's sarcoma, cervical cancer, and pancreatic cancer. [11] It is administered by intravenous injection. [11] There is also an albumin-bound formulation. [11]
The rare gene – discovered in 1994 - was found to increase the chances of developing breast and ovarian cancer. ... Drugs that are already used in the treatment of ovarian, breast and prostate ...
Ads
related to: weekly chemo for ovarian cancer